PL2828300T3 - Sposób wytwarzania chitozanu o niskiej zawartości endotoksyn - Google Patents

Sposób wytwarzania chitozanu o niskiej zawartości endotoksyn

Info

Publication number
PL2828300T3
PL2828300T3 PL13719131T PL13719131T PL2828300T3 PL 2828300 T3 PL2828300 T3 PL 2828300T3 PL 13719131 T PL13719131 T PL 13719131T PL 13719131 T PL13719131 T PL 13719131T PL 2828300 T3 PL2828300 T3 PL 2828300T3
Authority
PL
Poland
Prior art keywords
producing low
low endotoxin
endotoxin chitosan
chitosan
producing
Prior art date
Application number
PL13719131T
Other languages
English (en)
Polish (pl)
Inventor
June Gladman
Craig Hardy
Andrew HOGGARTH
Original Assignee
Medtrade Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Limited filed Critical Medtrade Products Limited
Publication of PL2828300T3 publication Critical patent/PL2828300T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Sustainable Development (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
PL13719131T 2012-03-23 2013-03-25 Sposób wytwarzania chitozanu o niskiej zawartości endotoksyn PL2828300T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1205174.4A GB201205174D0 (en) 2012-03-23 2012-03-23 Process for producing low endotoxin chitosan
EP13719131.8A EP2828300B1 (en) 2012-03-23 2013-03-25 Process for producing low endotoxin chitosan
PCT/GB2013/050775 WO2013140190A1 (en) 2012-03-23 2013-03-25 Process for producing low endotoxin chitosan

Publications (1)

Publication Number Publication Date
PL2828300T3 true PL2828300T3 (pl) 2018-09-28

Family

ID=46087039

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13719131T PL2828300T3 (pl) 2012-03-23 2013-03-25 Sposób wytwarzania chitozanu o niskiej zawartości endotoksyn

Country Status (15)

Country Link
US (2) US11485798B2 (instruction)
EP (1) EP2828300B1 (instruction)
JP (1) JP6226950B2 (instruction)
CN (2) CN113773411A (instruction)
AU (1) AU2013237185B2 (instruction)
BR (1) BR112014023585B1 (instruction)
CA (1) CA2868148C (instruction)
DK (1) DK2828300T3 (instruction)
ES (1) ES2667271T3 (instruction)
GB (2) GB201205174D0 (instruction)
IN (1) IN2014DN08783A (instruction)
NO (1) NO2828300T3 (instruction)
PL (1) PL2828300T3 (instruction)
PT (1) PT2828300T (instruction)
WO (1) WO2013140190A1 (instruction)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3120997B2 (ja) 1990-07-18 2000-12-25 ヤマハ発動機株式会社 自動二輪車におけるエンジン吸気系配設構造
GB201309606D0 (en) 2013-05-29 2013-07-10 Medtrade Products Ltd Process for producing low endotoxin chitosan
GB201309607D0 (en) * 2013-05-29 2013-07-10 Medtrade Products Ltd Process for producing low endotoxin chitosan
GB2514592A (en) * 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
GB2514597A (en) 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
CN105256650B (zh) * 2015-10-05 2017-03-29 福建农林大学 一种纳米纤维素固载乳酸/壳聚糖载药纳米微球多功能造纸涂料及其制备方法
US12084570B2 (en) * 2019-09-11 2024-09-10 American University Chitosan as an intumescing, thermoformable flame retardant
CN116253809B (zh) * 2023-04-19 2024-11-05 广州润虹医药科技股份有限公司 一种去除壳聚糖中内毒素的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195175A (en) * 1978-01-03 1980-03-25 Johnson Edwin L Process for the manufacture of chitosan
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5169535A (en) * 1989-09-22 1992-12-08 Kurita Water Industries Ltd. Method of removing endotoxin
JP2000256403A (ja) * 1999-03-05 2000-09-19 Ymc Co Ltd 部分アシル化キトサン粒子およびその製造法
US7080688B2 (en) * 2003-08-14 2006-07-25 Halliburton Energy Services, Inc. Compositions and methods for degrading filter cake
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
CN1833732A (zh) 2005-03-17 2006-09-20 李毅彬 一种抗菌医用敷料的制造方法及其用途
JP5632125B2 (ja) * 2005-06-14 2014-11-26 ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． 部分的脱アセチル化キチン誘導体の組成物
EP2035338B1 (en) * 2006-06-02 2020-10-07 Synedgen, Inc. Method for producing a chitosan-arginine compound
US20080248508A1 (en) 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
WO2008063503A2 (en) * 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
GB2463523B (en) * 2008-09-17 2013-05-01 Medtrade Products Ltd Wound care device
CN101579353A (zh) * 2009-06-09 2009-11-18 中国人民解放军第二军医大学 温敏性几丁糖制剂及其制备与应用
JP5653068B2 (ja) * 2010-05-06 2015-01-14 焼津水産化学工業株式会社 低分子量キトサンの製造方法
CN102086239A (zh) * 2011-01-17 2011-06-08 西南大学 抗凝血蚕蛹壳聚糖衍生物的制备方法

Also Published As

Publication number Publication date
GB2500817A (en) 2013-10-02
ES2667271T3 (es) 2018-05-10
JP2015511663A (ja) 2015-04-20
AU2013237185A1 (en) 2014-11-13
CA2868148A1 (en) 2013-09-26
PT2828300T (pt) 2018-04-09
CA2868148C (en) 2019-05-28
BR112014023585B1 (pt) 2022-01-04
GB201305417D0 (en) 2013-05-08
WO2013140190A1 (en) 2013-09-26
EP2828300A1 (en) 2015-01-28
US20150080335A1 (en) 2015-03-19
US11498981B2 (en) 2022-11-15
NO2828300T3 (instruction) 2018-06-30
CN104603155A (zh) 2015-05-06
JP6226950B2 (ja) 2017-11-08
US11485798B2 (en) 2022-11-01
IN2014DN08783A (instruction) 2015-05-22
AU2013237185B2 (en) 2017-10-05
GB201205174D0 (en) 2012-05-09
DK2828300T3 (en) 2018-05-22
BR112014023585A2 (instruction) 2017-06-20
US20160168277A1 (en) 2016-06-16
CN104603155B (zh) 2021-08-17
EP2828300B1 (en) 2018-01-31
CN113773411A (zh) 2021-12-10

Similar Documents

Publication Publication Date Title
ZA201500603B (en) Process
GB201216921D0 (en) Process
GB201207997D0 (en) Process
HUE049113T2 (hu) Gyártási rendszer
PL2828300T3 (pl) Sposób wytwarzania chitozanu o niskiej zawartości endotoksyn
EP2900698A4 (en) PROCESS FOR PRODUCING POLYMERS
GB201214326D0 (en) Process
GB201500761D0 (en) Process
GB2515188B (en) Process for producing low endotoxin chitosan
GB201219224D0 (en) Process
GB201318062D0 (en) Process
SG11201406779SA (en) Method for producing polymer
EP2852660A4 (en) PROCESS
ZA201502344B (en) Process
EP2814867A4 (en) PROCESS FOR POLYMER MANUFACTURE
GB2515187B (en) Process for producing low endotoxin chitosan
SG11201501567QA (en) Method for producing 7-octenal
PL2918614T3 (pl) Sposób wytwarzania polimeru
GB201317561D0 (en) Process
GB201316604D0 (en) Process
IL234526A (en) METHOD FOR PRODUCING DIETHINE TETRACARBOXIMIDES
EP2831054A4 (en) IMPROVED PROCESS FOR THE PRODUCTION OF (S) -EQUOL
IL236126A (en) Process for making 4-cyclohexyl-2-methyl-2-butanol
GB201223071D0 (en) Process
GB201222686D0 (en) Process